Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has
launched its over-the-counter (OTC) Fexofenadine Hydrochloride and
Pseudoephedrine Hydrochloride Extended Release Tablets 60 mg / 120 mg, a
bioequivalent generic version of Allegra-D® 12 Hour Allergy &
Congestion, in the U.S. market on November 18, 2014.
for Dr. Reddy’s Announces the Launch of Over-the-Counter Fexofenadine Hydrochloride 60 mg and Pseudoephedrine Hydrochloride 120 mg Extended-Release Tablets investment picks